Graham Capital Management L.P. Purchases Shares of 11,650 Phibro Animal Health Co. (NASDAQ:PAHC)

Graham Capital Management L.P. purchased a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 11,650 shares of the company's stock, valued at approximately $245,000.

Several other large investors also recently modified their holdings of PAHC. Deutsche Bank AG grew its stake in Phibro Animal Health by 90.8% in the 4th quarter. Deutsche Bank AG now owns 16,873 shares of the company's stock valued at $354,000 after buying an additional 8,032 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new position in Phibro Animal Health in the 4th quarter valued at approximately $1,119,000. CastleKnight Management LP grew its stake in Phibro Animal Health by 6.2% in the 4th quarter. CastleKnight Management LP now owns 389,433 shares of the company's stock valued at $8,178,000 after buying an additional 22,796 shares in the last quarter. Cetera Investment Advisers purchased a new position in Phibro Animal Health in the 4th quarter valued at approximately $204,000. Finally, Centiva Capital LP purchased a new position in Phibro Animal Health in the 4th quarter valued at approximately $266,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Price Performance

NASDAQ:PAHC traded up $0.22 during trading hours on Friday, hitting $23.24. The stock had a trading volume of 135,439 shares, compared to its average volume of 199,023. The company has a 50 day simple moving average of $20.29 and a two-hundred day simple moving average of $21.88. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a one year low of $16.16 and a one year high of $26.55. The firm has a market capitalization of $942.01 million, a price-to-earnings ratio of 48.42, a P/E/G ratio of 0.45 and a beta of 0.62.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The firm had revenue of $347.80 million during the quarter, compared to the consensus estimate of $352.41 million. Research analysts forecast that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is currently 61.54%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research note on Thursday, May 8th. Finally, Barclays lifted their price objective on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and an average target price of $20.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.